困难菌感染;新的治疗方法和未来的前景
Charmaine Normington1,2, Caroline H Chilton1,2, Anthony M Buckley3
1Healthcare Associated Infections Research Group, School of Medicine, Faculty of Health and Medicine, University of Leeds.
Current opinion in gastroenterology
|November 9, 2023
概括
对Clostridioides difficile感染 (CDI) 的新疗法为应对这一迫切威胁提供了希望. 研究重点是微生物保护疗法和抗生素替代品,以对抗复发性CDI.
科学领域:
- 微生物学 微生物学
- 传染性疾病 传染性疾病
- 胃肠病学 胃肠病学
背景情况:
- 困难杆菌感染 (CDI) 是一个主要的全球健康问题,被美国疾病预防控制中心确定为紧急威胁.
- 肠道感染源于肠道微生物组的不平衡,通常由抗生素使用引发,矛盾的是,需要抗生素治疗,导致复发.
研究的目的:
- 审查当前和新兴的Clostridioides difficile感染的治疗方法.
- 为管理CDI提供未来治疗策略的视角.
主要方法:
- 审查最近的临床发现和治疗CDI的进展.
- 分析微生物组失生症在CDI复发中的作用.
- 探索超越传统抗生素的新型治疗类别.
主要成果:
- 由于复发率较低,建议在一线CDI治疗中使用Fidaxomicin,这是一种节约微生物群的抗生素.
- 便微生物群移植 (FMT) 和定义的微生物组生物治疗药物显示出作为抗生素辅助剂的承诺,用于管理复发性CDI.
- 未来的疗法旨在通过向潜在的微生物组失调来减少对抗生素的依赖.
结论:
- 新型向治疗对于改善复发性CDI治疗成功至关重要.
- 虽然长期影响需要进一步研究,但扩大CDI治疗武器库为临床医生提供了多样化的解决方案.
- 解决CDI需要采取多方面的方法来减少患者的痛苦,并打击这种重要的传染病.
相关概念视频
Microorganisms in Medicine and Therapeutics
35
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
35
Inflammatory Bowel Disease IV: Pharmacological Management
134
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
134
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
170
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
170
Drugs for Treatment of Diarrhea-Predominant IBS
186
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
186
Fungal Phylum Microsporidia
21
Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
21
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
122
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
122


